These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3392128)

  • 1. Correlation between predicted and measured digoxin serum concentrations.
    Tayeb OS; Al-Fares AM; el-Sayed YM; Islam SI
    J Clin Pharm Ther; 1988 Apr; 13(2):159-63. PubMed ID: 3392128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cystatin C is not a better marker of creatinine or digoxin clearance than serum creatinine.
    O'Riordan S; Ouldred E; Brice S; Jackson SH; Swift CG
    Br J Clin Pharmacol; 2002 Apr; 53(4):398-402. PubMed ID: 11966673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steady-state concentrations and dosage of digoxin in relation to kidney function in hospitalized patients over 70 years of age.
    Algotsson A; Sanz E; Alván G
    J Intern Med; 1991 Mar; 229(3):247-51. PubMed ID: 2007843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of serum digoxin concentration monitoring by fluorescence polarization immunoassay on the TDxFLx and dry chemistry enzyme immunoassay on the Vitros 950.
    Solnica B
    Clin Chem Lab Med; 2004; 42(8):958-64. PubMed ID: 15387450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency of individual dosage of digoxin with calculated concentration.
    Zhao L; Yang P; Li P; Wang X; Qin W; Zhang X
    Clin Interv Aging; 2014; 9():1205-10. PubMed ID: 25092970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
    Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
    Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can digoxin dose requirements be predicted?
    Dobbs SM; Mawer GE; Rodgers M; Woodcock BG; Lucas SB
    Br J Clin Pharmacol; 1976 Apr; 3(2):231-7. PubMed ID: 973957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum digoxin concentration: dependence on body weight and age].
    Kaufmann G; Neumann P
    Schweiz Med Wochenschr; 1977 Nov; 107(47):1695-9. PubMed ID: 929130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of digoxin dosage in VLBW infants using serum creatinine concentrations.
    Gortner L; Hellenbrecht D
    Acta Paediatr Scand; 1986 May; 75(3):433-8. PubMed ID: 3728003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steady-state kinetics of digoxin in the elderly.
    Roberts MA; Caird FI
    Age Ageing; 1976 Nov; 5(4):214-23. PubMed ID: 1008007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of two-point assay of digoxin serum concentration in studying population pharmacokinetics in Egyptian pediatric patients with heart failure: does it make sense?
    el-Desoky ES; Madabushi R; Amry Sel-D; Bhattaram VA; Derendorf H
    Am J Ther; 2005; 12(4):320-7. PubMed ID: 16041195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update.
    Yukawa E; Honda T; Ohdo S; Higuchi S; Aoyama T
    J Clin Pharmacol; 1997 Feb; 37(2):92-100. PubMed ID: 9055134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive performance of four pharmacokinetic methods for calculating digoxin dosage.
    el-Sayed YM
    J Clin Pharm Ther; 1995 Oct; 20(5):297-304. PubMed ID: 8576297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment.
    Okada RD; Hager WD; Graves PE; Mayersohn M; Perrier DG; Marcus FI
    Circulation; 1978 Dec; 58(6):1196-203. PubMed ID: 709776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of two prediction models for digoxin dosing.
    Markantonis SL; Kyroudis A; Christopoulos T
    Pharm World Sci; 1993 Feb; 15(1):29-33. PubMed ID: 8485504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic prediction of serum digoxin concentration in the elderly.
    Mooradian AD; Wynn EM
    Arch Intern Med; 1987 Apr; 147(4):650-3. PubMed ID: 3827452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of population-based and Bayesian methods to individualize digoxin doses shortly after the start of therapy for atrial fibrillation.
    Chrystyn H; Dean S
    J Clin Pharm Ther; 1991 Jun; 16(3):177-85. PubMed ID: 1869597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous digoxin-like immunoreactivity in elderly patients with normal serum creatinine concentrations.
    Lackner TE; Lau BW; Parvin C; Valdes R
    Clin Pharm; 1988 Jun; 7(6):449-53. PubMed ID: 3402180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring endogenous digoxin-like substance and exogenous digoxin in the serum of low-birth-weight infants.
    Ng PK; LeGatt D; Coates J; Collins-Nakai RL
    Am J Hosp Pharm; 1985 Sep; 42(9):1977-9. PubMed ID: 3901741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.